Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular fibrinogen + tranexamic acid for bleeding reduction in total knee arthroplasty
IRCT20191013045091N2Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2025
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative hemorrhage comparing Fibrinogen + tranexamic acid with Placebo (2 arms). Primary endpoints: Hemoglobin, Hematocrit and 8 more. Started Dec 2025; status: completed.
02
Drugs
Fibrinogen humantranexamic acid
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on IRCT20191013045091N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191013045091N2.